443TiPFirst-in-human trial design for W0101: A first-in-class antibody-drug conjugate targeting IGF-1R and identification of the target patient population.
Saved in:
| Title: | 443TiPFirst-in-human trial design for W0101: A first-in-class antibody-drug conjugate targeting IGF-1R and identification of the target patient population. |
|---|---|
| Authors: | Gomez-Roca, C A1 (AUTHOR), Garralda-Cabanas, E2 (AUTHOR), Cruzalegui, F3 (AUTHOR), Ausseil, F3 (AUTHOR), Zorza, G3 (AUTHOR), Delfour, O3 (AUTHOR), Besse, J3 (AUTHOR), Akla, B4 (AUTHOR), Gautier, S5 (AUTHOR), Adam, J6 (AUTHOR) |
| Source: | Annals of Oncology. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1093/annonc/mdy279.430 |
